PAGE 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 12,
1996
ARCHER-DANIELS-MIDLAND COMPANY
(Exact name of Registrant as specified in its charter)
Delaware 1-44 41-0129150
(State or other (Commission (I.R.S. Employer
jurisdiction File Number) Identification No.)
of incorporation)
4666 Faries Parkway
Decatur, Illinois 62526
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
217/424-5200
Not Applicable
(Former name or former address, if changed since last
report)
1
PAGE 2
Item 5. Other Events
ADM confirms that it is participating in an agreement to
settle the federal class action lawsuits filed against several
companies involving the sale of lysine. Without admitting to
any of the conduct alleged, but to avoid the enormous
uncontrollable costs of protracted litigation, ADM has agreed
with other companies to contribute to a settlement fund. ADM's
contribution to the settlement fund would be $25 million. The
settlement covers all of the federal class action suits with
respect to the sale of lysine. This settlement would not
resolve any lawsuits filed in state court by direct and
indirect purchasers of lysine. Formal papers seeking court
approval of the settlement were filed in the United States
District Court for the Northern District of Illinois on April
12, 1996.
2
PAGE 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
ARCHER-DANIELS-MIDLAND COMPANY
______________________________
R. P. Reising
Vice President, Secretary and
General Counsel
Dated: April 16, 1996
3
